Oncological microdissection testicular sperm extraction (Onco-microTESE) outcomes for fertility preservation of patients with testicular cancer with azoospermia or severe oligoasthenoteratozoospermia
Reproductive Health
Related content
COMMENTED
Uro-Oncology
Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK Study
★ 1
Recommended and commented by
Prof. Dr Richard Cathomas, Faculty Member
Eur Urol
Freedland SJ, Mulhall JP, Gleave M, Giorgi U, Saad F, Rannikko A, Ivanova JI, Nasr AF, Reisman AL, Ganguli A, Kral P, Turnbull J, Shore N
doi: 10.1016/j.eururo.2025.02.006
Further Publications Urology
Robot-assisted nephroureterectomy: surgical and mid-term oncological outcomes in over 1100 patients (ROBUUST 2.0 collaborative group)
BJU Int
Ditonno F, Franco A, Wu Z, Wang L, Abdollah F, Simone G, Correa AF, Ferro M, Perdonà S, Amparore D, Bhanvadia R, Brönimann S, Puri D, Mendiola DF, Ben-David R, Moon SC, Yong C, Moghaddam FS, Ghoreifi A, Bologna E, Licari LC, Finati M, Tuderti G, Helstrom E, Tozzi M, Tufano A, Rais-Bahrami S, Sundaram CP, Mehrazin R, Gonzalgo ML, Derweesh IH, Porpiglia F, Singla N, Margulis V, Antonelli A, Djaladat H, Autorino R
doi: 10.1111/bju.16526
Uro-Oncology
Treatment patterns and oncological outcomes of older adults with metastatic prostate cancer in real-world setting
J Am Geriatr Soc
Wenzel M, Hoeh B, Wagner N, Koll F, Siech C, Humke C, Steuber T, Graefen M, Tilki D, Kluth L, Traumann M, Banek S, Chun FKH, Mandel P
doi: 10.1111/jgs.19045
Uro-Oncology
Deep and Durable Prostate-specific Antigen Response to Darolutamide with Androgen Deprivation Therapy and Docetaxel, and Association with Clinical Outcomes for Patients with High- or Low-volume Metastatic Hormone-sensitive Prostate Cancer: Analyses of the Randomized Phase 3 ARASENS Study
Eur Urol
Saad F, Hussain MHA, Tombal B, Fizazi K, Sternberg CN, Crawford ED, Nordquist LT, Bögemann M, Tutrone R, Shore ND, Belkoff L, Fralich T, Jhaveri J, Srinivasan S, Li R, Verholen F, Kuss I, Smith MR
doi: 10.1016/j.eururo.2024.03.036
Uro-Oncology
Outcome of Subsequent Therapies After (177)Lu-Vipivotide Tetraxetan for Metastatic Castrate-Resistant Prostate Cancer: A Tertiary Cancer Center Experience
Prostate
Losee M, Kavanaugh M, Liu M, Borges N, Haberman V, Ritzer J, Wolanski A, Bhimaniya S, Choudhury AD, Hyun H, Stoltenberg H, Kilbridge KL, Morgans A, Pomerantz M, Robertson M, Sakellis C, Shah H, Taplin ME, Wei XX, Ng T, Ravi P, Jacene H
doi: 10.1002/pros.24880
Erectile and Sexual Functions and Dysfunctions
Pseudoephedrine for ejaculatory dysfunction after retroperitoneal lymph node dissection in testicular cancer
BJU Int
Conduit C, Lewin J, Hong W, Sim IW, Ahmad G, Leonard M, O'Haire S, Moody M, Hutchinson AD, Lawrentschuk N, Thomas B, Dhillon HM, Tran B
doi: 10.1111/bju.16481
Further Publications Gynecology
Utility and Outcomes of Ovarian Tissue Cryopreservation and Transplantation for Gynecologic Cancers: A Systematic Review and Meta-analysis
Obstet Gynecol
Erden M, Gayete-Lafuente S, Vural NA, Oktay KH
doi: 10.1097/AOG.0000000000005708
Uro-Oncology
Risk Stratification of Patients with Recurrence After Primary Treatment for Prostate Cancer: A Systematic Review
Eur Urol
Weiner AB, Kakani P, Armstrong AJ, Bossi A, Cornford P, Feng F, Kanabur P, Karnes RJ, Mckay RR, Morgan TM, Schaeffer EM, Shore N, Tree AC, Spratt DE
doi: 10.1016/j.eururo.2024.04.034
Further Publications Urology
Correction Rates and Clinical Outcomes in Hospitalized Adults With Severe Hyponatremia: A Systematic Review and Meta-Analysis
JAMA Intern Med
Ayus JC, Moritz ML, Fuentes NA, Mejia JR, Alfonso JM, Shin S, Fralick M, Ciapponi A
doi: 10.1001/jamainternmed.2024.5981